Compared with the clade II mpox virus (MPXV) outbreak in adults that started in May 2022, the ongoing clade I MPXV outbreak in Africa is causing severe illness and higher mortality.
The U.S. Centers for Disease Control and Prevention (CDC) reported on May 16, 2024, that the increasing number of reported suspected clade I mpox cases in the Democratic Republic of the Congo (DRC) poses a global threat for potential spread.
Is the United States Prepared for Mpox Clade I Arrival
New Malaria Vaccine Shipments Begin
With the World Health Organization (WHO) 's recent Prequalification, a second malaria vaccine may soon become available in various countries.
The WHO estimates that the demand for malaria vaccines will be 40–60 million doses annually by 2026.
Meningococcal Cases Linked to Recent Travel
The Centers for Disease Control and Prevention (CDC) today issued a Health Alert Network (HAN) Health Advisory to notify healthcare providers about cases of meningococcal disease associated with Umrah, which is conducted in the Kingdom of Saudi Arabia (KSA).
Meningococcal disease, caused by Neisseria meningitidis, is a rare but severe illness with a 10–15% case-fatality rate.
Bisoprolol Does Not Reduce Exacerbations in At-Risk COPD Patients
No reduction seen in number of self-reported exacerbations treated with oral corticosteroids, antibiotics, or both
Long COVID Definitions, Care Models Are Evolving
Care models are informed by five key principles, including multidisciplinary expertise, patient-centered approach